Protein S-100B--a prognostic marker for cerebral damage

Area of Science:

• Neuroscience
• Biomarkers
• Neurological Disorders

Background:

• S-100B protein is a biomarker for neurological damage.
• Its release kinetics differ based on injury type and severity.
• Understanding S-100B temporal profiles is crucial for diagnosis and prognosis.

Purpose of the Study:

• To review the clinical utility of S-100B measurements in acute and chronic neurological disorders.
• To compare S-100B assessment with clinical and neuroimaging data.
• To highlight the advantages and limitations of S-100B as a biomarker.

Main Methods:

• Literature review of studies assessing S-100B in neurological conditions.
• Analysis of temporal release patterns of S-100B.
• Comparison of S-100B data with clinical outcomes and neuroimaging findings.

Main Results:

• S-100B levels correlate with symptom severity and outcome in acute neurological disorders (hypoxia, stroke, TBI).
• Immediate S-100B release is observed in TBI, while delayed release occurs in ischemic stroke due to blood-brain barrier changes.
• Limited data exists on S-100B's value in chronic brain diseases.

Conclusions:

• S-100B is a valuable biomarker for acute neurological injury severity and outcome.
• The temporal dynamics of S-100B release are informative but depend on the specific pathophysiology.
• Further research is needed to establish the clinical significance of S-100B quantification in chronic neurological conditions.